Combined oral contraceptives and antiretroviral PK/PD in Malawian women: pharmacokinetics and pharmacodynamics of a combined oral contraceptive and a generic combined formulation antiretroviral in Malawi

J Acquir Immune Defic Syndr. 2011 Oct 1;58(2):e40-3. doi: 10.1097/QAI.0b013e31822b8bf8.
No abstract available

Publication types

  • Controlled Clinical Trial
  • Letter
  • Research Support, N.I.H., Extramural

MeSH terms

  • Adult
  • Anti-HIV Agents / pharmacokinetics*
  • Anti-HIV Agents / therapeutic use
  • Area Under Curve
  • Contraceptives, Oral, Combined / blood
  • Contraceptives, Oral, Combined / pharmacokinetics*
  • Drug Therapy, Combination
  • Ethinyl Estradiol / blood
  • Ethinyl Estradiol / pharmacokinetics
  • Feasibility Studies
  • Female
  • HIV Seronegativity
  • HIV Seropositivity / blood*
  • HIV Seropositivity / drug therapy*
  • Humans
  • Lamivudine / pharmacokinetics
  • Lamivudine / therapeutic use
  • Levonorgestrel / blood
  • Malawi
  • Nevirapine / pharmacokinetics
  • Nevirapine / therapeutic use
  • Norgestrel / pharmacokinetics
  • Ovulation Inhibition / drug effects*
  • Progesterone / blood
  • Stavudine / pharmacokinetics
  • Stavudine / therapeutic use
  • Young Adult

Substances

  • Anti-HIV Agents
  • Contraceptives, Oral, Combined
  • Lamivudine
  • Norgestrel
  • Ethinyl Estradiol
  • Progesterone
  • Levonorgestrel
  • Nevirapine
  • Stavudine